[CEA monitoring of gynecologic tumor patients using a simplified CEA-radioimmunoassay].
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D005260:Female; D005833:Genital Neoplasms, Female / Q000175:diagnosis*; D006801:Humans; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000188:drug therapy; D011863:Radioimmunoassay / Q000379:methods*; D011933:Reagent Kits, Diagnostic; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis; D014594:Uterine Neoplasms / Q000175:diagnosis
D000970:Antineoplastic Agents; D002272:Carcinoembryonic Antigen; D011933:Reagent Kits, Diagnostic
CEA-Verlaufsstudie gynäkologischer Tumor-Patienten unter Verwendung eines vereinfachten CEA-Radioimmunoassays.